Clinical Guides
Nasal Polyps
A clinically focused guide to recognising chronic rhinosinusitis with nasal polyps, excluding dangerous unilateral disease, and selecting topical therapy, systemic steroids, surgery or biologics in an Indian care pathway.
MedNext Academy | 14 min read
Nasal Polyps
A clinically focused guide to recognising chronic rhinosinusitis with nasal polyps, excluding dangerous unilateral disease, and selecting topical therapy, systemic steroids, surgery or biologics in an Indian care pathway.
Summary
Nasal polyps are pale, oedematous inflammatory protrusions of sinonasal mucosa. In adults they most often occur as part of chronic rhinosinusitis with nasal polyps, defined by at least 12 weeks of compatible symptoms plus objective evidence on nasal endoscopy or computed tomography. Nasal blockage or discharge is central; reduced smell, facial pressure, sleep disturbance and impaired work may accompany it. The label is a phenotype, not a complete aetiological diagnosis: diffuse bilateral disease may be type-2 inflammatory, whereas localized or unilateral tissue demands a search for a secondary inflammatory, fungal, odontogenic, structural or neoplastic cause.
The initial consultation must separate stable chronic disease from emergencies. Visual loss, diplopia, ophthalmoplegia, proptosis, severe frontal headache, meningism, focal neurology, altered consciousness or rapidly progressive facial swelling suggests orbital or intracranial complication and needs emergency assessment. Recurrent unilateral blood-stained discharge, facial numbness, cranial neuropathy, a firm irregular mass or destructive imaging is not routine polyposis. Children with polyps require evaluation for an underlying condition rather than automatic treatment as adult disease.
Treatment aims to restore nasal airflow and smell, reduce exacerbations and systemic steroid exposure, improve sleep and quality of life, and control asthma or other linked disease. Saline irrigation and regular intranasal corticosteroid are foundational. Short oral corticosteroid courses, endoscopic sinus surgery and biologic therapy are escalation options for selected severe uncontrolled disease; none is a permanent cure and each requires benefit-risk review. Antibiotics treat a defined bacterial problem, not the polyp itself. Histopathology is essential when appearance, laterality or operative findings are atypical.
How Common Is It?
Chronic rhinosinusitis is common internationally, but a prevalence figure for all chronic rhinosinusitis cannot be relabelled as the prevalence of nasal polyps. EPOS 2020 estimates chronic rhinosinusitis at roughly 5–12% of the general population and describes chronic rhinosinusitis with nasal polyps as a smaller adult phenotype. Studies differ in whether they use symptoms alone, physician diagnosis, endoscopy, computed tomography or procedure records. Symptom-only surveys overcount disease because allergic rhinitis, septal deviation, migraine and recurrent viral illness can resemble it; operative series undercount people without surgical access.
Polyps are uncommon in young children and their presence should prompt a secondary-cause assessment. Adult prevalence increases with age and is associated with asthma, non-steroidal anti-inflammatory drug-exacerbated respiratory disease and other type-2 inflammatory conditions. Recurrence after apparently adequate treatment is frequent, particularly in severe eosinophilic disease, but recurrence rates depend on follow-up duration, surgical extent, adherence to topical therapy and how recurrence is defined. A visible small polyp, a need for revision surgery and loss of disease control are different outcomes.
Robust contemporary Indian population data using endoscopy-confirmed definitions are limited. Tertiary rhinology clinics see a selected population with more severe, recurrent or anatomically complex disease, so their case mix should not be projected nationally. Geographic variation in allergy, air pollution, occupational exposures, fungal sensitisation, asthma recognition and access to endoscopy or computed tomography can shape recorded burden. Counselling should therefore use the individual symptom score, smell function, endoscopic findings, prior steroid or surgery history and comorbid asthma rather than an unsupported national percentage or a promise that one intervention prevents recurrence.
Risk Factors
Type-2 airway inflammation is a major driver of diffuse bilateral adult polyposis. Ask about asthma, wheeze, atopic disease, eosinophilia and reactions after aspirin or other cyclo-oxygenase-1 inhibiting non-steroidal anti-inflammatory drugs. The combination of asthma, nasal polyps and respiratory reactions to these medicines suggests NSAID-exacerbated respiratory disease; patients should not undertake an unsupervised aspirin challenge or desensitisation. Severe asthma and recurrent polyps often travel together, so upper- and lower-airway control should be reviewed as one problem rather than by isolated clinics.
Secondary chronic rhinosinusitis may reflect cystic fibrosis, primary ciliary dyskinesia, immunodeficiency, vasculitis, odontogenic infection, fungal disease, a foreign body, prior trauma or surgery, mucociliary impairment or an anatomical obstruction. Childhood polyps, repeated unusual infections, bronchiectasis, infertility, failure to thrive, systemic inflammatory symptoms or a unilateral pattern increase the value of targeted investigation. Allergic fungal rhinosinusitis is an inflammatory condition with characteristic allergic mucin and imaging; it is not proved by a positive fungal culture alone and should not be equated with invasive fungal infection.
Tobacco smoke, occupational irritants and air pollution may worsen nasal and lower-airway symptoms, although an exposure history cannot establish the histological endotype. Review topical technique and adherence before declaring treatment failure. Repeated systemic corticosteroid courses themselves become a risk factor for diabetes, hypertension, infection, osteoporosis, cataract, adrenal suppression and mood effects. Prior sinus surgery does not eliminate inflammatory biology, and poor postoperative topical access can contribute to recurrence. A unilateral lesion is a diagnostic risk marker rather than a conventional risk factor: inverted papilloma, malignancy, antrochoanal polyp or other localized pathology must be considered even in a person who also has allergy.
Diagnosis
History
Confirm at least 12 weeks of nasal obstruction or discharge and ask about smell loss, facial pressure, sleep, snoring, mouth breathing, dental symptoms and impact on work. Establish side, tempo and bleeding: persistent unilateral obstruction, blood-stained discharge, facial numbness, orbital symptoms or rapid progression changes the pathway. Record asthma, NSAID reactions, atopy, previous steroid exposure, operations, infections, immunosuppression and childhood lung or growth problems. Use a validated patient-reported measure such as SNOT-22 to quantify burden, not to replace examination.
Examination
Assess airway and systemic illness first, then inspect the external nose, eyes, facial sensation, oral cavity and dentition. Anterior rhinoscopy may show smooth, pale, insensitive tissue, but diagnostic nasal endoscopy better defines bilateral versus localized disease, middle-meatal oedema, discharge, crusting, necrosis, contact bleeding and postoperative anatomy. Polyps are not simply enlarged turbinates. Examine for proptosis, diplopia, impaired eye movements, reduced visual acuity, cranial neuropathy, cervical nodes and asthma signs. Do not repeatedly manipulate a vascular-looking or friable unilateral mass.
Investigations
Objective confirmation uses endoscopy or computed tomography; routine plain sinus radiographs add little. CT of the paranasal sinuses is appropriate for surgical planning, treatment-resistant disease, suspected complication or uncertain anatomy, but imaging changes alone do not diagnose symptomatic chronic rhinosinusitis. MRI complements CT when there is suspected tumour, orbital or intracranial extension, perineural spread, encephalocele or difficult soft-tissue characterization. Obtain histopathology from unilateral, atypical, friable, necrotic or surgically removed tissue according to local protocol. Target blood count, eosinophils, allergy, immune, vasculitic, fungal, dental or genetic testing to the phenotype; indiscriminate panels create false positives.
Differential Diagnosis
Inferior turbinate hypertrophy from allergic or non-allergic rhinitis can resemble polyps on limited inspection but is vascular, anatomically expected and responsive to decongestion in a way a true polyp is not. A deviated septum, concha bullosa, adenoidal tissue, rhinitis medicamentosa and nasal valve collapse can produce obstruction without a polyp. Acute viral or bacterial rhinosinusitis causes shorter-duration symptoms. Migraine, tension-type headache, neuropathic pain and temporomandibular disease commonly explain facial pain when endoscopy and imaging do not support sinus inflammation.
Localized lesions require deliberate differentiation. An antrochoanal polyp usually arises from the maxillary sinus and extends posteriorly; inverted papilloma may be unilateral and has recurrence and malignant-transformation implications. Juvenile nasopharyngeal angiofibroma is a vascular tumour classically presenting in an adolescent boy with recurrent epistaxis and obstruction and must not be biopsied casually. Sinonasal squamous carcinoma, adenocarcinoma, lymphoma, melanoma, salivary-type malignancy and metastasis may masquerade as a polyp. Encephalocele, meningoencephalocele and glioma are critical developmental mimics, particularly when superior, congenital or associated with clear rhinorrhoea.
Inflammatory alternatives include allergic fungal rhinosinusitis, eosinophilic mucin disease, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, sarcoidosis and IgG4-related disease. Invasive fungal rhinosinusitis is a different, rapidly destructive emergency, usually in diabetes, neutropenia or substantial immunosuppression; pain, fever, necrotic mucosa, cranial neuropathy or orbital findings are warnings. Odontogenic sinusitis, foreign body and an obstructed sinus from a dental or neoplastic cause are often unilateral. The useful differential is organized by laterality, immune state, tempo, bleeding, tissue appearance and imaging rather than by assuming every smooth intranasal swelling is benign polyposis.
Management
Explain that chronic rhinosinusitis with polyps is usually controllable but recurrent. Teach high-volume isotonic saline irrigation using sterile, distilled, appropriately filtered, or previously boiled and cooled water; device hygiene matters. Regular intranasal corticosteroid is first-line anti-inflammatory treatment. Demonstrate direction away from the septum and a technique that reaches the nasal cavity rather than the throat. Review adherence, tolerability, smell, symptom score and endoscopy after an adequate interval. Manage allergic rhinitis, asthma and NSAID-exacerbated disease collaboratively and address smoke or occupational irritants without overstating causality.
A short systemic corticosteroid course may temporarily improve severe obstruction or smell in selected adults, but repeated courses accumulate substantial harm. It is not a substitute for follow-up. Endoscopic sinus surgery is considered when appropriate medical therapy fails, complications occur, diagnosis requires tissue, or disease burden remains unacceptable. Surgery removes obstructing disease and improves ventilation and topical access; continuing postoperative saline and intranasal steroid is usually needed. Discuss bleeding, infection, adhesions, recurrence, smell outcome, orbital injury, cerebrospinal-fluid leak and anaesthetic risk, with risks individualized to anatomy and procedure.
Biologics target type-2 inflammation and are reserved for carefully selected severe uncontrolled disease after specialist phenotyping and shared decision-making. current guidelines supports dupilumab as add-on to intranasal corticosteroid for a defined national health services subgroup with prior surgery, inadequate control after systemic corticosteroids or surgery, and SNOT-22 at least 50; this commissioning threshold is not an Indian licence or funding rule. Compare biologic access, response criteria, long-term injections, adverse effects and uncertain optimal duration against revision surgery and standard care. Stop ineffective treatment through a documented review plan rather than continuing indefinitely.
Prescribing Information
Intranasal corticosteroids are the core medicine. Product, age licence, dose and device differ, so prescribe from the current Indian label or formulary rather than copying a foreign brand schedule. Local adverse effects include dryness, irritation and epistaxis; check that the spray is aimed laterally and examine persistent bleeding. Systemic absorption is generally low at recommended doses but cumulative exposure matters when the patient also uses inhaled, topical, oral or injected corticosteroids. Children, pregnancy, glaucoma risk and repeated high-dose use need individualized review. Saline is not interchangeable with a drug and must be prepared with microbiologically safe water.
Oral corticosteroids may be considered as a brief specialist-directed rescue in severe disease. Before prescribing, assess diabetes, blood pressure, active infection, tuberculosis risk, peptic disease, bone health, psychiatric history, pregnancy and interacting medicines. Document expected benefit, duration, gastroprotection or glucose monitoring when indicated, and the cumulative number of courses. Long-term oral corticosteroid maintenance for polyps is poor practice because toxicity rises while control is temporary. Antibiotics are not routine polyp treatment; use them only when a bacterial infection is clinically supported and choose agent and duration from local antimicrobial guidance. Antifungals are not routine therapy for uncomplicated chronic rhinosinusitis with polyps.
Dupilumab is a prescription biologic given with intranasal corticosteroid for selected severe uncontrolled adult disease under applicable regulatory and specialist criteria. Review hypersensitivity, conjunctival or ocular symptoms, eosinophilic complications, live-vaccine considerations and relevant helminth infection in accordance with the current product information. Do not use an eosinophil count alone as authorization. Other biologics have jurisdiction-specific indications and evidence; interchangeability cannot be assumed. Aspirin desensitisation for NSAID-exacerbated disease belongs in an experienced service because respiratory reactions and gastrointestinal or bleeding harms require supervision.
When to Refer
Refer routinely to ENT when symptoms persist despite a correctly used intranasal corticosteroid and saline trial, when diagnosis is uncertain, when polyps prevent adequate examination, or when recurrent disease, major smell loss, sleep impairment or asthma interaction needs endoscopy and treatment planning. Include duration, laterality, bleeding, smell, asthma and NSAID history, prior operations, actual steroid courses, topical technique, dental symptoms and relevant immune features. Transfer prior CT images and operative or pathology reports, not merely their summaries. Children with confirmed polyps should reach paediatric ENT or an appropriate multidisciplinary service for secondary-cause assessment.
Use an urgent suspected-neoplasm pathway for unilateral or atypical tissue, recurrent unilateral blood-stained discharge, facial numbness, cranial neuropathy, a hard or friable lesion, cervical nodes, palatal change or unexplained destructive imaging. A patient already labelled with polyps can still develop another pathology; prior benign histology does not permanently clear a new unilateral lesion. Rapid specialist review is also needed for possible invasive fungal disease in a person with uncontrolled diabetes, neutropenia, transplant or major immunosuppression.
Emergency transfer is required for reduced vision, diplopia, ophthalmoplegia, proptosis, marked periorbital oedema with systemic illness, meningism, focal neurological deficit, altered consciousness, severe frontal swelling or rapidly progressive necrosis. Coordinate respiratory referral for difficult asthma or suspected NSAID-exacerbated respiratory disease. Rhinology, allergy or immunology input may be needed for biologic assessment, immune deficiency, vasculitis or complex recurrence. In India, choose a centre that can actually provide endoscopy, cross-sectional imaging, pathology and safe surgery; give an explicit safety-net while travel, cost or referral delays are being resolved.
Red Flags
Unilateral disease is the dominant diagnostic warning. A single-sided mass, especially with blood-stained discharge, spontaneous epistaxis, facial pain or numbness, loose teeth, trismus, ear effusion, cranial-nerve deficit, orbital symptoms, palatal bulge or cervical lymphadenopathy, must not be treated indefinitely as an allergic polyp. Friability, necrosis, irregular attachment or bone destruction increases concern. Do not perform an unplanned office biopsy of a lesion that could be vascular or connected to the skull base; imaging and specialist planning come first. Histology is required when tissue is atypical or removed.
Orbital and intracranial complications are time-critical. Reduced acuity or colour vision, relative afferent pupillary defect, diplopia, restricted eye movement, proptosis, severe orbital pain, rapidly increasing periorbital swelling, meningism, altered behaviour, seizure, focal deficit or severe frontal headache requires emergency ENT, ophthalmology, neurosurgical and imaging capability as indicated. A normal temperature does not exclude dangerous disease in immunosuppression. Black or anaesthetic mucosa, disproportionate facial pain and cranial neuropathy in diabetic ketoacidosis, neutropenia or transplant raise concern for acute invasive fungal rhinosinusitis.
Clear unilateral watery rhinorrhoea that increases with straining or follows trauma or surgery may represent cerebrospinal-fluid leakage; avoid casual instrumentation. A new polyp in a child, severe recurrent infections, bronchiectasis or poor growth warrants an underlying-disease work-up. Repeated systemic steroid prescriptions without diagnosis review are also a safety warning because they can mask lymphoma, fungal infection or vasculitis while causing metabolic and infectious harm. Safety-net any new bleeding, visual change, facial sensory loss, rapidly worsening pain, fever with swelling or neurological symptom, even when bilateral inflammatory polyps were previously documented.
Indian Clinical Context
High-quality first-contact care does not require immediate expensive testing. Confirm chronicity, examine both sides, identify unilateral and orbital warnings, review asthma and NSAID reactions, teach saline and intranasal-steroid technique, and avoid unnecessary antibiotics or serial oral steroid packs. Endoscopy improves diagnostic confidence but may be unavailable outside district or teaching hospitals. CT should answer a clinical or surgical question; repeating scans after every symptom fluctuation adds radiation and cost. When referral is needed, specify urgency and send images, not only a printed report.
Indian differentials require attention to uncontrolled diabetes, tuberculosis, immunosuppressive treatment, dental infection and fungal disease without assuming that every opacity is fungal. Allergic fungal rhinosinusitis can be chronic and non-invasive, whereas acute invasive fungal disease is an emergency; the terms must not be conflated. Pathology capacity is essential for unilateral, recurrent, atypical or operative specimens. If immunohistochemistry or expert head-and-neck review is unavailable locally, retain blocks and slides and plan referral rather than accepting a nonspecific label that conflicts with clinical behaviour.
Cost and availability shape escalation. Intranasal medicines and saline are more accessible than biologics, while surgery, postoperative debridement, pathology and long-term follow-up may require travel. A biologic recommendation from current guidelines or a European licence does not establish Indian reimbursement, market availability or affordability. Confirm the current Indian regulator-approved indication and institutional criteria. Shared decision-making should compare cumulative steroid toxicity, revision surgery, injection burden, monitoring and probable adherence. The NMC curriculum makes nasal-polyp assessment a core undergraduate skill, but independent endoscopy, biopsy, biologic selection and sinus surgery remain supervised specialist practice.
NMC Competency Mapping
The 2024 NMC CBME curriculum directly assigns nasal polyps to EN4.27: learners should elicit, document and present a correct history, describe clinical features, choose investigations and explain management principles. EN4.32 links acute and chronic sinusitis with its complications, while EN4.33 covers tumours of the nose, nasopharynx and paranasal sinuses. EN2.5 supports selection of relevant biochemical, microbiological and pathological investigations, and EN2.6 covers appropriate radiological studies. Anatomy and pathology foundations include the nasal cavity, paranasal sinuses, orbit and relevant epithelial or tumour morphology.
At Know How and Show How level, a learner should distinguish chronic inflammatory symptoms from an emergency, ask about laterality and bleeding, integrate asthma and NSAID reactions, inspect the nose safely, interpret a supplied endoscopic description and CT report, and choose when histology is necessary. They should explain saline and topical-steroid technique, the temporary role and harms of systemic steroids, the purpose and limitations of surgery, and why a biologic decision needs specialist phenotyping and jurisdiction-specific approval.
Assessment should include a bilateral recurrent inflammatory case, an immunosuppressed patient with pain and orbital signs, and a unilateral bleeding mass. Credit belongs to diagnostic discipline, not to naming the newest biologic. Learners must state that allergic fungal rhinosinusitis is not synonymous with invasive fungal infection and that antibiotics do not shrink uncomplicated polyps. Reading this guide does not certify nasal endoscopy, biopsy, CT interpretation, aspirin challenge, biologic prescribing or endoscopic sinus surgery. The quarantined draft still requires organizational clinical review before any publication decision.
Key Exam Pearls for NEET PG
Chronic rhinosinusitis requires at least 12 weeks of symptoms, with nasal obstruction or discharge central to the clinical definition and objective confirmation by endoscopy or CT. Bilateral pale insensitive masses are typical inflammatory polyps; hypertrophied turbinates are vascular, anatomically located and may shrink with decongestion. Ethmoidal polyps are commonly multiple and bilateral, whereas an antrochoanal polyp is usually unilateral and extends from the maxillary sinus toward the choana. A unilateral adult nasal mass is neoplastic until adequately evaluated, not until proven by appearance alone.
Asthma, nasal polyps and respiratory reactions to aspirin or other COX-1 NSAIDs form NSAID-exacerbated respiratory disease. Allergic fungal rhinosinusitis is a non-invasive eosinophilic inflammatory disorder with allergic mucin and characteristic radiological features; acute invasive fungal rhinosinusitis occurs in susceptible hosts and threatens orbit, brain and life. Visual loss, ophthalmoplegia, proptosis, cranial neuropathy, meningism and altered consciousness are emergency findings. CT defines bone and surgical anatomy; MRI is superior for selected soft-tissue, orbital, intracranial, perineural or skull-base questions.
Regular intranasal corticosteroid and saline irrigation are foundational. A short oral steroid course can improve symptoms but repeated exposure causes cumulative harm. Endoscopic sinus surgery improves drainage and topical access but does not erase inflammatory recurrence, so postoperative topical treatment continues. Biologics are add-on options for selected severe uncontrolled type-2 disease, not first-line treatment for every polyp. current guidelines uses a narrow public health subgroup for dupilumab and should not be memorized as an Indian entitlement. EN4.27 is the direct NMC nasal-polyp competency; EN4.32 covers sinusitis complications and EN4.33 protects against missing sinonasal tumour.
Frequently Asked Questions
Does every unilateral nasal polyp need urgent specialist assessment?
A persistent unilateral mass needs prompt ENT assessment because antrochoanal polyp, inverted papilloma, fungal disease, encephalocele and malignancy may resemble an inflammatory polyp. Urgency increases with bleeding, facial numbness, cranial-nerve or orbital signs, nodes, rapid growth or destructive imaging. Specialist imaging should precede biopsy when a vascular or skull-base lesion is possible.
Can intranasal corticosteroid sprays permanently cure nasal polyps?
They control mucosal inflammation, improve symptoms and help reduce recurrence, but they do not guarantee permanent elimination of chronic inflammatory disease. Technique and consistent use matter. Persistent severe symptoms need diagnostic review rather than endless repeat prescriptions, and some patients require surgery or a specialist-assessed biologic while continuing topical treatment.
When should a biologic be considered for chronic rhinosinusitis with polyps?
Biologics are reserved for selected severe uncontrolled disease after confirmation of diagnosis, assessment of type-2 features, review of adherence and standard treatment, and comparison with surgery. Eligibility, licensed indication, response criteria, cost and continuation rules vary by country. A foreign reimbursement threshold or a raised eosinophil count alone is not sufficient.
Are antibiotics or antifungal medicines routinely required for nasal polyps?
No. Polyps are inflammatory tissue, so routine antibiotics do not shrink them and promote adverse effects and resistance. Antibiotics are used for a clinically supported bacterial infection under local guidance. Antifungals are not routine treatment for uncomplicated polyposis; invasive fungal disease is a separate emergency needing urgent tissue, imaging, surgery and specialist antimicrobial management.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic